UPDATES & NEWS — 2 MIN READ
Deloitte features Mendel in their "Intelligent Trials" Report
Deloitte features Mendel in their "Intelligent Trials" Report
Mendel.ai is improving identification of suitable cancer patients and matching to clinical trials. Mendel.ai, a US-based company founded in 2016, uses AI tools to analyse clinical data, including medical history and genetic analysis, from cancer patients. Its goal is to facilitate clinical trials in
oncology research by organising and analysing RWD, and matching patients to the right clinical trials.45
They take medical data from many structured and unstructured data sets and turn these into data
digitised patient journeys aligned to specific treatments. Having collected data on over 1 million journeys,
its algorithm can segment patient populations by their demographic, such as how African American
women with breast cancer respond to a particular drug. In essence creating in silico or patient-less
trials. The AI algorithm built on these data helps trial recruitment by finding eligible patients.